EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Conformational landscapes of rigid and flexible molecules explored with variable temperature ion mobility-mass spectrometry
AZN: Upcoming Executive Order to Ease U.S. Drug Manufacturing Regulations | AZN Stock News
Astrazeneca's AZD-0022 solid preclinical results support further development | BioWorld
11,407 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Bearing Point Capital LLC
Mercer Global Advisors Inc. ADV Invests $10.49 Million in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Beacon Pointe Advisors LLC
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Itau Unibanco Holding S.A.
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Buy" from Analysts
Here's what top C-suites are saying about tariffs
Alembic Pharma's generic Ticagrelor tablets gets U.S. FDA nod - The Hindu
AstraZeneca (AZN) Achieves Major Milestones in Asthma Treatment Trials
Alembic receives FDA nod for AstraZeneca clotbuster generic
BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma | AZN Stock News
AstraZeneca (AZN) Triple Therapy Shows Promise in Asthma Trials | AZN Stock News
AstraZeneca's New Asthma Treatment Shows Strong Results In Late-stage Trials
Clinical trial underway to assess effectiveness and safety of potential Long Covid treatment
Astrazeneca Pharma India Ltd Stock Price: Astrazeneca Phar Share Price Today | India Infoline
AI-enabled risk assessment for lung cancer reaches 5 million people around the world
Shore Capital Reiterates Buy Rating for AstraZeneca (LON:AZN)
AI by AstraZeneca spots lung cancer signs in 5 million people, enables early diagnosis - India Today
AstraZeneca's AI lung cancer screening program executes 5 mn tests, flags 50k individuals at high risk
AstraZeneca PLC (NASDAQ:AZN) Sees Large Decrease in Short Interest
AstraZeneca, Qure.ai complete AI-enabled assessment of 5 million chest X-rays for lung cancer
Lung Cancer Detection: AI-enabled risk assessment reaches 5 million people around the world
I think this could be the best investment opportunity on the FTSE 100
'Everything is possible': Pharmas navigate US market uncertainties | BioWorld
Zillions And Zillions: UCB Launches Myasthenia Gravis Campaign 05/01/2025
Kepler Capital Remains a Hold on AstraZeneca (AZN) | Markets Insider
AstraZeneca wins set-aside in Germany
AstraZeneca (AZN) Contemplates U.S. Production Expansion Amid Tariff Concerns | AZN Stock News
Guardian Capital LP Acquires 4,497 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Kovitz Investment Group Partners LLC
AstraZeneca (LON:AZN) Receives "Buy" Rating from Shore Capital
AstraZeneca to scrap trails of Truqap in prostate cancer after interim analysis
AstraZeneca PLC (AZN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...
In the clinic for April 30, 2025 | BioWorld
Q1 2025 AstraZeneca PLC Earnings Call Transcript
PCSK9 Inhibitors Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotechnology, Novo Nordisk, AstraZeneca, Akeso | ABNewswire
AstraZeneca (AZN) Q1 2025 Earnings Highlight 10% Revenue Growth
AstraZeneca to appeal invalidated diabetes patent in generics dispute
AstraZeneca moves some production to US amid tariff threat
AZN: EsoBiotec to Present Promising Data on ENaBL-T for CAR-T Therapies | AZN Stock News
AstraZeneca's (AZN) Calquence Combo Receives EU Approval Recommendation | AZN Stock News
AstraZeneca PLC (AZN) to Showcase Innovative In Vivo CAR-T Cell Therapy at ASGCT Annual Meeting ...
AstraZeneca says potential US tariffs manageable; faces another China fine | Company News - Business Standard
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs | AstraZeneca | The Guardian
AstraZeneca (AZN) Confirms 2025 Sales Forecast Amid Potential U.S. Tariffs | AZN Stock News
AstraZeneca (AZN) Reports Q1 Revenue Below Expectations, Highlights Key Advancements | AZN ...
AstraZeneca 'firmly committed' to US amid tariff threat
AstraZeneca (AZN) Reports Mixed Q1 Results Amid Strong Growth Forecast | AZN Stock News
AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China - 2nd Update | Morningstar
News Highlights: Top Company News of the Day - Tuesday at 5 AM ET | Morningstar
SOPHiA GENETICS Expands AstraZeneca Partnership to Advance Liquid Biopsy Worldwide
AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China - Update | Morningstar
AstraZeneca has built resilient supply chains in U.S., China: CEO
AstraZeneca (AZN) Reports Strong Q1 Earnings and Reiterates Guidance
AstraZeneca's Q1 2025 Financial Results | AZN Stock News
In Vivo CAR T-Cell Market Future Innovations with Lipid Nanoparticles Viral Vectors and Oncolytic Viruses 2025 to 2034
Global Ovarian Cancer Drugs Market is projected to reach the value of $11,128.94 Million by 2030
City round-up: SysGroup update; AstraZeneca first quarter; Regent slams Inspired board | TheBusinessDesk.com
AstraZeneca Sales, Earnings Rise | Morningstar
Other news to note for April 29, 2025 | BioWorld
AstraZeneca: Calquence-based Regimens For CLL Recommended For EU Approval; Discontinues Truqap Trial
AstraZeneca Q1 Results Climb, Maintains FY25 Outlook; Lifts Dividend
D3S-001 in advanced solid tumors with KRAS G12C mutations: a phase 1 trial
AZN Q1 2025 Earnings Report on 4/29/2025
AstraZeneca PLC (OSTO:AZN) Q1 2025: Everything You Need To Know Ahead Of Earnings
AstraZeneca (AZN) Set to Release Q1 Earnings, EPS Expected to Drop
AstraZeneca (AZN) Advances Trastuzumab Deruxtecan and Neratinib Study | AZN Stock News
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR | The Manila Times
SOPHiA Genetics (SOPH) Expands Liquid Biopsy Collaboration with AstraZeneca
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy ...
AstraZeneca (AZN) Expands Global Reach of Innovative Liquid Biopsy Test | AZN Stock News
SOPHiA GENETICS Expands Global Collaboration With AstraZeneca To Advance Liquid Biopsy Testing
AstraZeneca (AZN) Faces Lowered Price Target Amid Potential Earnings Pressures | AZN Stock News
Adage Capital Partners GP L.L.C. Takes Position in AstraZeneca PLC (NASDAQ:AZN)
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus
Decongestion in heart failure: medical and device therapies
AstraZeneca PLC (NASDAQ:AZN) Stake Increased by MGO One Seven LLC
Biz Updates
Why Tempus AI Inc. (TEM) Soared Last Week
AstraZeneca (AZN) Gains EMA Approval for Expanded Calquence Indication | AZN Stock News
Leerink Partnrs Boosts Earnings Estimates for AstraZeneca
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Price T Rowe Associates Inc. MD
Stifel Financial Corp Decreases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
First Trust Advisors LP Buys 82,595 Shares of AstraZeneca PLC (NASDAQ:AZN)
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
Mr. Thomas O'Shaughnessy reports ONCO-INNOVATIONS' INKA HEAL
Development Zones
AstraZeneca's new project in Qingdao reaches milestone
30,000 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Diadema Partners LP
Latest news
Show more
Morning Note: Cautious Optimism on US-China Trade; AMD & Arista Reports Loom
Morning Note: Palantir's Report in Focus; Stable Swiss CPI; US Services Data Due
